(This Twitter compilation was extremely easy to curate and annotate using a free service called Storify. You don’t even need to have a Twitter account to do it. In fact, you don’t even need a Twitter account to follow a conference hashtag. Feel free to contact us via our website if you’d like to learn how; we'd be glad to share!)
We've created this blog to share our perspective on happenings and trends in the pharmaceutical, device, and supplement industry. We welcome your feedback.
Showing posts with label ACRP2014. Show all posts
Showing posts with label ACRP2014. Show all posts
Thursday, May 1, 2014
A Curated Collection of Tweets from ACRP 2014
Some Polaris staff members attended ACRP last month in San Antonio. It was a great conference. See what we and other attendees had to say about a few key sessions here.
(This Twitter compilation was extremely easy to curate and annotate using a free service called Storify. You don’t even need to have a Twitter account to do it. In fact, you don’t even need a Twitter account to follow a conference hashtag. Feel free to contact us via our website if you’d like to learn how; we'd be glad to share!)
(This Twitter compilation was extremely easy to curate and annotate using a free service called Storify. You don’t even need to have a Twitter account to do it. In fact, you don’t even need a Twitter account to follow a conference hashtag. Feel free to contact us via our website if you’d like to learn how; we'd be glad to share!)
Labels:
ACRP,
ACRP2014,
Hermansky-Pudlak,
HPS,
rare disease,
rare diseases,
RBM,
Risk-based Monitoring
Subscribe to:
Posts (Atom)